drugset / Trial / NCT05001763

Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical Cystectomy

NCT05001763

RandomizedParallel-groupSingle-blindTreatment

Summary

The first purpose is to determine whether prucalopride can promote the recovery of intestinal function after robot-assisted laparoscopic radical cystectomy and urinary diversion. The secondary objectives is to speed up postoperative ventilation, defecation, reduce the time of first solid food tolerance, reduce postoperative hospital stay, reduce the incidence of readmission due to intestinal obstruction and the incidence of complications within 180 days.

Timeline

Start
2021-09-01
Primary completion
2023-09-01
Completion
2023-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Prucalopride Small molecule 2 mg